Non-Surgical Treatment of Obstructive Sleep Apnea (OSA)

(10-Mark MD Exam Answer)

Definition and Context

1. General Measures (Lifestyle Modification)
2. Positional Therapy
3. Pharmacological Therapy
4. Positive Airway Pressure (PAP) Devices
5. Oral/Mandibular Appliances
6. Other Adjunct Non-surgical Devices

1. General Measures (Lifestyle Modification)

• Strongly recommended for all overweight/obese patients (BMI typically 30-40 in OSA clinic patients)
• At least 9 randomized clinical trials support comprehensive lifestyle intervention vs. no intervention for moderate-to-severe OSA
• Even a 10% weight loss reduces the AHI (Apnea-Hypopnea Index) by ~26%
• A dose-response relationship exists - more substantial weight loss produces greater AHI reduction
• Mechanism: reduces volumes of upper airway soft tissue, including tongue fat, as shown by upper airway imaging
• Recommended program: reduced-calorie diet + exercise + behavioral counseling
• Bariatric surgery achieves dramatic results but is a separate (surgical) intervention

• Alcohol (especially in the evening), benzodiazepines, opioids, muscle relaxants, and sedative-hypnotics all worsen OSA by:
  • Reducing upper airway muscle tone
  • Increasing airway collapsibility
  • Suppressing the arousal response
• These agents should be strictly avoided

• Adequate sleep duration must be maintained
• Sleep deprivation worsens upper airway muscle control

• Addressed further under positional therapy

• Nasal obstruction increases upper airway resistance and promotes mouth breathing, worsening OSA
• Nasal corticosteroid sprays, antihistamines, and decongestants can reduce nasal resistance and improve CPAP tolerance

2. Positional Therapy

• Positional OSA (POSA) - OSA occurring predominantly or exclusively in the supine position - is present in slightly more than one-third of all OSA patients
• In the supine position, the tongue and soft palate fall posteriorly, narrowing the pharynx
• Treatment: keeping the patient in the lateral (non-supine) position during sleep
• Methods include:
  • Tennis ball technique (ball sewn into back of pajamas)
  • Positional alarms (vibrating devices worn on the back)
  • Wedge/positional pillows
  • Electronic positional trainers
• Positional therapy is an excellent first-line treatment for POSA, particularly as a stand-alone option or in combination with other therapies
• Adherence can be monitored with positional tracking devices

3. Positive Airway Pressure (PAP) Therapy

Mechanism of Action

• Facilitates a larger end-expiratory lung volume
• Creates distal tracheal traction, further stabilizing the upper airway
• Eliminates obstructive apneas, hypoxemias, snoring, and sleep fragmentation

Types of PAP Devices

CPAP - Clinical Details

• Treatment of choice for moderate-to-severe OSA
• Optimal pressure determined during overnight PSG (polysomnography) titration
• Pressure range: typically 5-20 cm H₂O
• CPAP with expiratory pressure relief (EPR/C-Flex) improves comfort and adherence
• Benefits documented: improved cognitive function, reduced cardiovascular events, normalized EDS, better quality of life, reduction in BP (especially nocturnal hypertension)

PAP Adherence (Key Issue)

• Adherence is the primary clinical challenge; definition: >4 hours/night on >70% of nights
• Factors affecting adherence: mask fit, claustrophobia, pressure intolerance, dry mouth/nose, aerophagia, skin irritation
• Interventions to improve adherence:
  • Heated humidification (most important - reduces nasal dryness and congestion)
  • Proper mask fitting (nasal, nasal pillow, or full-face mask)
  • Pressure ramp feature for comfortable sleep onset
  • Regular follow-up, especially shortly after initiation
  • Cognitive behavioral therapy (CBT) for CPAP adherence
  • Telemedicine monitoring

4. Oral Appliances (Mandibular Devices)

Types

• Most commonly used oral appliance
• Mechanism: positions the mandible anteriorly, which advances the tongue and increases the posterior airway space, reducing pharyngeal collapsibility
• Custom-fabricated by a trained dentist/orthodontist (takes ~3 months)
• Effective for: mild-to-moderate OSA, snoring, positional OSA
• Less effective than CPAP for severe OSA but may be preferred due to better adherence
• Requires intact dentition (contraindicated in significant dental disease)
• Side effects: temporomandibular joint (TMJ) pain, tooth soreness, excessive salivation, dry mouth, occlusal changes with long-term use

• Uses a suction bulb to hold the tongue forward
• Alternative for edentulous patients
• Less commonly used; generally less comfortable than MAD

Comparison with CPAP

• CPAP is more effective at reducing AHI
• Oral appliances have better patient acceptance and adherence
• Outcome equivalence has been shown in some studies due to the adherence advantage

5. Pharmacological Therapy

• Modafinil / Armodafinil - wake-promoting agents; useful as adjunct for residual EDS in patients on adequate CPAP
• Solriamfetol - dopamine and norepinephrine reuptake inhibitor; approved for residual EDS in OSA
• Pitolisant - histamine H3 receptor antagonist/inverse agonist; activates histaminergic arousal pathways

• Protriptyline (tricyclic antidepressant): reduces REM sleep (when apneas are worst); rarely used today due to anticholinergic side effects
• Medroxyprogesterone: respiratory stimulant; minimal benefit
• SSRIs (e.g., fluoxetine, sertraline): some benefit in mild OSA by increasing upper airway muscle tone; not standard therapy
• Topical nasal corticosteroids: modest benefit in pediatric OSA

• Benzodiazepines
• Opioids
• Muscle relaxants
• Barbiturates
• All cause respiratory depression and/or reduce arousal response

6. Other Adjunct Non-Surgical Devices

• Expiratory positive airway pressure device placed over each nostril
• Generates expiratory resistance, creating intrinsic PEEP that stents the airway
• Suitable for mild-to-moderate OSA
• Example: Provent

• Applies negative pressure around the neck to enlarge the pharyngeal airway
• An alternative in CPAP-intolerant patients

• Exercises targeting tongue, soft palate, and pharyngeal muscles
• Strengthen upper airway dilator muscles
• Shown to reduce AHI by ~50% in adults and ~62% in children in meta-analyses
• Particularly useful as adjunct therapy

Summary Table

Key Exam Points

• CPAP is gold standard, effective in >70% of moderate-to-severe OSA
• The primary limitation of CPAP is adherence, not efficacy
• Weight loss is recommended in ALL overweight/obese OSA patients; 10% weight loss reduces AHI by 26%
• Oral appliances have comparable outcomes to CPAP in some studies due to better adherence
• Pharmacological therapy is not primary treatment; modafinil treats residual EDS, not OSA itself
• Alcohol, opioids, benzodiazepines must be avoided as they worsen OSA
• Positional OSA occurs in ~1/3 of patients and responds well to positional therapy alone